Cargando…
Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid Leukemia
It has been previously shown that the aldehyde dehydrogenase (ALDH) family member ALDH1A1 has a significant association with acute myeloid leukemia (AML) patient risk group classification and that AML cells lacking ALDH1A1 expression can be readily killed via chemotherapy. In the past, however, a re...
Autores principales: | Dancik, Garrett M., Varisli, Lokman, Tolan, Veysel, Vlahopoulos, Spiros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531322/ https://www.ncbi.nlm.nih.gov/pubmed/37761947 http://dx.doi.org/10.3390/genes14091807 |
Ejemplares similares
-
Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target
por: Varisli, Lokman, et al.
Publicado: (2023) -
The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia
por: Dancik, Garrett M., et al.
Publicado: (2023) -
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment
por: Dancik, Garrett M., et al.
Publicado: (2023) -
Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective
por: VARISLI, LOKMAN, et al.
Publicado: (2023) -
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
por: Gasparetto, Maura, et al.
Publicado: (2017)